LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

Search

Quidel Corp

Fermé

19.26 -3.26

Résumé

Variation du prix de l'action

24h

Actuel

Min

18.81

Max

19.99

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+54.83% upside

Dividendes

By Dow Jones

Prochains Résultats

6 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-54M

1.2B

Ouverture précédente

22.52

Clôture précédente

19.26

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 mars 2026, 20:38 UTC

Résultats

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

10 mars 2026, 23:57 UTC

Market Talk

Global Equities Roundup: Market Talk

10 mars 2026, 23:57 UTC

Market Talk

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

10 mars 2026, 23:47 UTC

Market Talk

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

10 mars 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

10 mars 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

10 mars 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

10 mars 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

10 mars 2026, 23:35 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

10 mars 2026, 23:06 UTC

Résultats

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

10 mars 2026, 22:51 UTC

Principaux Événements d'Actualité

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

10 mars 2026, 21:39 UTC

Acquisitions, Fusions, Rachats

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

10 mars 2026, 21:21 UTC

Résultats

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

10 mars 2026, 21:15 UTC

Résultats

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

10 mars 2026, 21:15 UTC

Acquisitions, Fusions, Rachats

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

10 mars 2026, 21:14 UTC

Résultats

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

10 mars 2026, 21:13 UTC

Résultats

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

10 mars 2026, 21:12 UTC

Résultats

Franco-Nevada 4Q Rev $597.3M >FNV

10 mars 2026, 21:12 UTC

Résultats

Franco-Nevada 4Q EPS $1.90

10 mars 2026, 20:57 UTC

Résultats

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mars 2026, 20:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

10 mars 2026, 20:44 UTC

Résultats

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mars 2026, 20:34 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

10 mars 2026, 20:34 UTC

Market Talk
Résultats

Oracle Building More Software for Less Money After Restructuring -- Market Talk

10 mars 2026, 20:23 UTC

Résultats

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mars 2026, 20:16 UTC

Résultats

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

10 mars 2026, 20:14 UTC

Résultats

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

10 mars 2026, 20:14 UTC

Résultats

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

10 mars 2026, 20:13 UTC

Résultats

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

10 mars 2026, 20:12 UTC

Résultats

Oracle Stock Jumps on Earnings Beat -- Barrons.com

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

54.83% hausse

Prévisions sur 12 Mois

Moyen 30.75 USD  54.83%

Haut 38 USD

Bas 25 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat